AUPH
Price
$8.01
Change
+$0.27 (+3.49%)
Updated
Jan 17 closing price
Capitalization
1.15B
45 days until earnings call
JSPR
Price
$5.51
Change
+$0.17 (+3.18%)
Updated
Jan 17 closing price
Capitalization
82.66M
Ad is loading...

AUPH vs JSPR

Header iconAUPH vs JSPR Comparison
Open Charts AUPH vs JSPRBanner chart's image
Aurinia Pharmaceuticals
Price$8.01
Change+$0.27 (+3.49%)
Volume$1.6M
Capitalization1.15B
Jasper Therapeutics
Price$5.51
Change+$0.17 (+3.18%)
Volume$722.12K
Capitalization82.66M
AUPH vs JSPR Comparison Chart
Loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUPH vs. JSPR commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUPH is a Hold and JSPR is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AUPH: $8.01 vs. JSPR: $5.51)
Brand notoriety: AUPH and JSPR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUPH: 109% vs. JSPR: 143%
Market capitalization -- AUPH: $1.15B vs. JSPR: $82.66M
AUPH [@Biotechnology] is valued at $1.15B. JSPR’s [@Biotechnology] market capitalization is $82.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUPH’s FA Score shows that 0 FA rating(s) are green whileJSPR’s FA Score has 2 green FA rating(s).

  • AUPH’s FA Score: 0 green, 5 red.
  • JSPR’s FA Score: 2 green, 3 red.
According to our system of comparison, JSPR is a better buy in the long-term than AUPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUPH’s TA Score shows that 4 TA indicator(s) are bullish while JSPR’s TA Score has 5 bullish TA indicator(s).

  • AUPH’s TA Score: 4 bullish, 3 bearish.
  • JSPR’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, AUPH is a better buy in the short-term than JSPR.

Price Growth

AUPH (@Biotechnology) experienced а -0.74% price change this week, while JSPR (@Biotechnology) price change was -21.84% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

AUPH is expected to report earnings on May 01, 2025.

JSPR is expected to report earnings on May 10, 2024.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUPH($1.15B) has a higher market cap than JSPR($82.7M). AUPH YTD gains are higher at: -10.802 vs. JSPR (-74.228). AUPH has higher annual earnings (EBITDA): 4.39M vs. JSPR (-67.27M). AUPH has more cash in the bank: 349M vs. JSPR (92.5M). JSPR has less debt than AUPH: JSPR (2.07M) vs AUPH (87.9M). AUPH has higher revenues than JSPR: AUPH (220M) vs JSPR (0).
AUPHJSPRAUPH / JSPR
Capitalization1.15B82.7M1,387%
EBITDA4.39M-67.27M-7%
Gain YTD-10.802-74.22815%
P/E RatioN/AN/A-
Revenue220M0-
Total Cash349M92.5M377%
Total Debt87.9M2.07M4,248%
FUNDAMENTALS RATINGS
AUPH: Fundamental Ratings
AUPH
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AUPHJSPR
RSI
ODDS (%)
N/A
Bullish Trend 11 days ago
69%
Stochastic
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 11 days ago
59%
Momentum
ODDS (%)
Bearish Trend 11 days ago
79%
Bearish Trend 11 days ago
59%
MACD
ODDS (%)
N/A
Bearish Trend 11 days ago
52%
TrendWeek
ODDS (%)
Bearish Trend 11 days ago
80%
Bearish Trend 11 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
84%
Bearish Trend 11 days ago
67%
Advances
ODDS (%)
Bullish Trend 24 days ago
79%
Bullish Trend 27 days ago
70%
Declines
ODDS (%)
Bearish Trend 13 days ago
83%
Bearish Trend 11 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 11 days ago
88%
Bullish Trend 11 days ago
53%
Aroon
ODDS (%)
Bullish Trend 11 days ago
82%
Bearish Trend 11 days ago
75%
View a ticker or compare two or three
Ad is loading...
AUPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COST943.1923.44
+2.55%
Costco Wholesale Corp
MGPI36.050.14
+0.39%
MGP Ingredients
RICK52.320.12
+0.23%
RCI Hospitality Holdings
KBR59.36-0.44
-0.74%
KBR
LEE12.15-0.42
-3.34%
Lee Enterprises

AUPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUPH has been loosely correlated with JSPR. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AUPH jumps, then JSPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUPH
1D Price
Change %
AUPH100%
+3.49%
JSPR - AUPH
44%
Loosely correlated
+3.18%
VCYT - AUPH
39%
Loosely correlated
-1.27%
GOSS - AUPH
37%
Loosely correlated
-3.81%
ADMA - AUPH
32%
Poorly correlated
-3.67%
SCPH - AUPH
32%
Poorly correlated
-4.09%
More

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
+3.18%
AUPH - JSPR
44%
Loosely correlated
+3.49%
ATNF - JSPR
38%
Loosely correlated
-1.27%
UBX - JSPR
35%
Loosely correlated
+2.37%
ATXI - JSPR
34%
Loosely correlated
+5.71%
AVXL - JSPR
34%
Loosely correlated
-9.26%
More